Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Monilethrix causes fragile, patchy hair loss.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Topical oxygen therapy may improve treatments for hair loss, acne, and chronic skin diseases with minimal side effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Photoacoustic imaging can accurately assess hair follicle density and orientation for hair transplant planning.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Ultrasound is a useful, non-invasive tool in dermatology for diagnosing skin conditions and guiding treatments, but it has some limitations.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.